Clinical Trial Update: Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for an intravenous proton pump inhibitor in patients with peptic ulcer hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Hemorrhage

Drugs mentioned

• Intravenous Proton Pump Inhibitor

Snippet

Sponsor: Lotung Poh-Ai Hospital | Conditions: Peptic Ulcer Hemorrhage | Phase 4 | Status: COMPLETED